PyInvesting

Market research

0155.KLSE Malaysian Genomics Resource Centre Bhd

KLSE MYR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
54M
P/E ratio
0.0
Analyst target
0.8
Dividend yield
Not available
Beta
0.14

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Malaysian Genomics Resource Centre Bhd is currently in a long term uptrend where the price is trading 47.6% above its 200 day moving average.

From a valuation standpoint, the stock is 2112.0% more expensive than other stocks from the Other sector with a price to sales ratio of 142.1.

Malaysian Genomics Resource Centre Bhd's total revenue sank by 97.3% to $136K since the same quarter in the previous year.

Its net income has dropped by 106.4% to $-2M since the same quarter in the previous year.

Finally, its free cash flow grew by 51.0% to $-3M since the same quarter in the previous year.

Based on the above factors, Malaysian Genomics Resource Centre Bhd gets an overall score of 2/5.